Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin-Reference-Cited by-同舟云学术

Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin

Published:2014-04-17 Issue:9 Volume:61 Page:1685-1689
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Soni Sandeep¹,Gross Thomas G.¹,Rangarajan Hemalatha¹,Baker K. Scott²,Sturm Mollie¹³,Rhodes Melissa¹

Affiliation:

1. Division of Hematology/Oncology/BMT; Nationwide Children's Hospital and Department of Pediatrics; The Ohio State University; Columbus Ohio

2. Clinical Research Division; Fred Hutchison Cancer Research Center; Seattle Washington

3. Division of Biostatistics; Nationwide Children's Hospital; Columbus Ohio

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25059/fullpdf

Reference21 articles.

1. Bone marrow transplantation for sickle cell disease;Walters;N Engl J Med,1996

2. Haematopoietic stem cell transplantation for sickle cell anaemia: The first 50 patients transplanted in Belgium;Vermylen;Bone Marrow Transplant,1998

3. Has stem cell transplantation come of age in the treatment of sickle cell disease;Shenoy;Bone Marrow Transplant,2007

4. Collaborative multicenter investigation of marrow transplantation for sickle cell disease: Current results and future directions;Walters;Biol Blood Marrow Transplant,1997

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA-identical sibling hematopoietic stem cell transplantation following reduced-toxicity myeloablative conditioning regimen in sickle cell disease;2023-05-03

2. A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease;Hematology;2023-02-02

3. Fertility preservation for pediatric patients with hemoglobinopathies: Multidisciplinary counseling needed to optimize outcomes;Frontiers in Endocrinology;2022-10-24

4. Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis;PharmacoEconomics - Open;2022-04-26

5. American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation;BLOOD ADV;2021